Veligrotug, sold under the brand name Lumvoa, is a monoclonal antibody medication used for the treatment of thyroid eye disease. It is an insulin-like growth factor-1 receptor inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.